Early clinical experience of a new heparinoid, ORG 10172, in prevention of deep venous thrombosis
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 45 (5) , 497-503
- https://doi.org/10.1016/0049-3848(87)90312-4
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effects of heparin, its low molecular weight fractions and other glycosaminoglycans on thrombus growthThrombosis Research, 1985
- Anticoagulant effects of a low molecular weight heparinoid (ORG 10172) in human volunteers and haemodialysis patientsThrombosis Research, 1985
- A comparison of the anti thrombotic and haemorrhagic effects of low molecular weight heparin fractions: The influence of the method of preparationThrombosis Research, 1984
- PROPHYLAXIS OF VENOUS THROMBOSIS AFTER MAJOR THORACIC SURGERYAnz Journal of Surgery, 1983
- USE OF A NEW HEPARINOID AS ANTICOAGULANT DURING ACUTE HAEMODIALYSIS OF PATIENTS WITH BLEEDING COMPLICATIONSThe Lancet, 1983
- A novel anti-thrombotic heparinoid (ORG 10172) devoid of bleeding inducing capacity: A survey of its pharmacological properties in experimental animal modelsThrombosis Research, 1982
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbitsBlood, 1982
- Prevention of Venous ThromboembolismSeminars in Thrombosis and Hemostasis, 1976
- Assay of heparin in plasma using a chromogenic substrate for activated factor XThrombosis Research, 1976
- Small Subcutaneous Doses of Heparin in Prevention of Venous ThrombosisNew England Journal of Medicine, 1973